(Q42727310)

5 November 2017

title

Platelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis (English)

1 reference

5 November 2017

1 reference

Jean-Baptiste Demoulin

6

1 reference

5 November 2017

Jean-Christophe Renauld

9

1 reference

5 November 2017

Sophie Lucas

7

0 references

Dominique Lison

object named as

Dominique Lison

10

0 references

author name string

Sandra Lo Re

1

1 reference

5 November 2017

Marylène Lecocq

2

1 reference

5 November 2017

Francine Uwambayinema

3

1 reference

5 November 2017

Yousof Yakoub

4

1 reference

5 November 2017

Monique Delos

5

1 reference

5 November 2017

Tim Sparwasser

8

1 reference

5 November 2017

François Huaux

11

1 reference

5 November 2017

language of work or name

English

0 references

publication date

25 August 2011

1 reference

American Journal of Respiratory and Critical Care Medicine

5 November 2017

published in

1 reference

5 November 2017

volume

184

1 reference

5 November 2017

issue

11

1 reference

5 November 2017

page(s)

1270-1281

1 reference

Strategies for treating idiopathic pulmonary fibrosis

5 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Update in diffuse parenchymal lung disease 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Integrating mechanisms of pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Roles of T lymphocytes in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Lymphocyte-macrophage alveolitis in nonsmoking individuals occupationally exposed to asbestos

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Regulation of pulmonary inflammation and fibrosis through expression of integrins alphaVbeta3 and alphaVbeta5 on pulmonary T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Dual roles of IL-4 in lung injury and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Control of regulatory T cell lineage commitment and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Pulmonary fibrosis: pathogenesis, etiology and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Regulatory T cell lineage specification by the forkhead transcription factor foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Imatinib therapy reduces radiation-induced pulmonary mast cell influx and delays lung disease in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Characterization of the effect of interleukin-10 on silica-induced lung fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

The role of pro- and anti-inflammatory responses in silica-induced lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

New developments in the understanding of immunology in silicosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Role of Interleukin-10 in the Lung Response to Silica in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Simian immunodeficiency virus-induced lymphatic tissue fibrosis is mediated by transforming growth factor beta 1-positive regulatory T cells and begins in early infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Intragraft FOXP3 protein or mRNA during acute renal allograft rejection correlates with inflammation, fibrosis, and poor renal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Reduced function of CD4+25+ regulatory T cell fraction in silicosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Regulation of PDGF and its receptors in fibrotic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Growth factors in idiopathic pulmonary fibrosis: relative roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

IL-17A-expressing T cells are essential for bacterial clearance in a murine model of hypersensitivity pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Role of interferon-gamma in the development of murine bronchus-associated lymphoid tissues induced by silica in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

The IL-4Ralpha pathway in macrophages and its potential role in silica-induced pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

Type 2 immune response associated with silicosis is not instrumental in the development of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0516OC

10.1164/RCCM.201103-0516OC

21 January 2018

Identifiers

DOI

1 reference

5 November 2017

1 reference